Single-arm Study | Extended focal ablation of localized prostate cancer with high-frequency irreversible electroporation.

Extended Focal Ablation of Localized Prostate Cancer With High-Frequency Irreversible Electroporation: A Nonrandomized Controlled Trial – JAMA Surgery (link to abstract – $ for full-text)

Commentary: Novel Focal Therapy Yields Low Rate of Serious Prostate Cancers — Trial’s 6-month rate of 6% was superior to historical control – MedPage Today (free registration required)

Related: Small study shows feasibility of MRI-guided focused ultrasound ablation for localized intermediate-risk prostate cancer

Commentary on Twitter

This single-arm objective performance criteria trial indicated excellent efficacy and safety profile of the second-generation high-frequency irreversible electroporation as primary treatment for localized prostate cancer. https://t.co/FheqcxJeA5

— JAMA Surgery (@JAMASurgery) July 7, 2022